05:33 PM EDT, 07/14/2025 (MT Newswires) -- Longevity Health ( XAGE ) said late Monday it will merge with THPlasma in an all-stock deal valued at $59 million plus $20 million earnout related to the achievement of financial results.

Longevity also terminated the 20/20 BioLabs transaction.

The company's deal with THPlasma, which operates a chain of plasma collection centers in the northeast US, is expected to close in Q4, subject to shareholders' approval and other closing conditions.

Longevity added that the combined entity is expected to continue to trade under ticker XAGE. Longevity Chief Executive Rajiv Shukla will be appointed as executive chairman after the merger, while THPlasma CEO George Chi will be named as co-chairman and CEO.

Shares of the company rose about 77% in recent after-hours activity.

Price: 4.67, Change: +2.02, Percent Change: +76.54